Choksi Laboratories Limited has issued a postal ballot notice dated February 7, 2026, seeking shareholder approval through e-voting for the appointment of Mr. Ritik Pavecha as Non-Executive Independent Director. The notice was submitted to BSE Limited on March 26, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Newspaper Publication Compliance

Following regulatory requirements, the company published confirmation of postal ballot notice dispatch in newspapers on March 27, 2026. The publication appeared in both English and Hindi editions to ensure comprehensive shareholder communication:

Key Voting Details

The postal ballot process follows a structured timeline with specific dates for shareholder participation:

Director Appointment Proposal

The special resolution seeks approval for the appointment of Mr. Ritik Pavecha (DIN: 08790431) as Non-Executive Independent Director for a term of 5 consecutive years commencing from February 7, 2026. The Board of Directors appointed him as Additional Independent Director on February 7, 2026, subject to shareholder confirmation.

Candidate Profile

Governance and Compliance

The company has appointed Ms. Surabhi Agrawal, FCS (COP.: 23696), Proprietor of M/s. Surabhi Agrawal & Associates, as the scrutinizer to conduct the postal ballot process. Central Depository Services (India) Limited (CDSL) has been engaged as the authorized agency for providing e-voting facility to shareholders.

In accordance with MCA circulars and SEBI regulations, the postal ballot notice is being sent only through electronic mode to shareholders whose email addresses are registered with the company, depositories, or Registrar and Transfer Agent. The notice is available on the company's website, BSE website, and CDSL's e-voting platform.

Voting Process

Shareholders holding shares in both physical and dematerialized form as on the cut-off date of March 20, 2026, are entitled to vote through the remote e-voting facility. The voting can be conducted through CDSL/NSDL e-voting system for individual shareholders in demat mode, CDSL e-voting system for physical shareholders and non-individual shareholders, and direct access through depository participant platforms.

Once votes are cast, shareholders will not be allowed to modify their voting decisions. The voting rights will be proportionate to the paid-up equity share capital held as on the cut-off date. Results will be communicated to stock exchanges and displayed on the company website upon completion of the scrutiny process.

Choksi Laboratories Limited has completed the publication of its unaudited financial results for the third quarter of FY26 ended December 31, 2025, in newspapers as mandated under Regulation 47 of SEBI (LODR) Regulations 2015. The analytical testing and calibration laboratory group published its financial results on February 8, 2026, in Free Press Journal (English edition) and Choutha Sansar (Hindi edition), following board approval on February 7, 2026.

Regulatory Compliance and Publication

The company formally notified BSE Limited on February 9, 2026, about the newspaper publication of its Q3FY26 financial results. This submission was made pursuant to Regulation 30 read with Schedule III Part A (A) and in compliance with Regulation 47(1)(b) of the SEBI (LODR) Regulations 2015. The notification included newspaper clippings as evidence of publication in both English and Hindi editions.

Financial Performance Overview

The company's Q3FY26 results showed remarkable improvement compared to the corresponding period in the previous year, with net profit witnessing exceptional growth:

For the nine-month period ended December 31, 2025, the company reported revenue from operations of ₹3,318.37 lakhs compared to ₹3,038.28 lakhs in the corresponding nine-month period of FY25, representing a growth of 9.22%. The nine-month net profit increased substantially to ₹93.75 lakhs from ₹60.20 lakhs in the previous year.

Exceptional Item and Income Components

During Q3FY26, Choksi Laboratories recorded an exceptional gain of ₹77.80 lakhs from the sale of an office flat. This non-recurring transaction was classified as an exceptional item as it does not form part of the company's ordinary operating activities. Other income for the quarter totaled ₹13.34 lakhs, comprising interest income of ₹0.58 lakhs, interest on IT refund of ₹13.26 lakhs, cash back on credit card of ₹0.21 lakhs, and forex gain of ₹1.10 lakhs.

Board Leadership Changes

The board meeting resulted in significant leadership transitions that will shape the company's governance structure:

Mr. Ritik Pavecha brings qualified expertise in audit, assurance, corporate compliance, governance, and regulatory advisory. The company affirmed that he is not debarred from holding directorship by SEBI or any other authority and holds no equity shares in the company.

Corporate Communication

The regulatory filing was submitted by Prakhar Dubey, Compliance Officer and Company Secretary, from the company's corporate office located at Survey No 9/1, Near Tulsiyana Industrial Park, Gram Kumerdi, Indore, Madhya Pradesh. The communication referenced the company's ISIN (INE493D01013) and BSE Code (526546), ensuring proper identification for regulatory purposes.